You are here: Industry Insights > cGMP

News List

Cascade Chemistry Begins $14M cGMP Mfg. Capacity Expansion contractpharma
February 20, 2021
Cascade Chemistry, a pharmaceutical CDMO, began construction of new facilities to increase capacity to manufacture APIs under cGMP.
CDMO Northway Biotech Expands in U.S. contractpharma
January 22, 2021
Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site in Europe, has opened its new 30,000-square-foot process ...
Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area prnasia
January 21, 2021
Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site in Europe, announced at the virtual grand opening ceremony ...
Stelis BioSource Continues Facility Investment contractpharma
November 13, 2020
Contract development and manufacturing organization (CDMO), Stelis BioSource, a division of Stelis Biopharma Pvt.
Argonaut Manufacturing Services Completes First cGMP Run contractpharma
November 09, 2020
New automated aseptic fill/finish line for clinical and commercial use was recently approved by regulators.
TFF Expands Engagement with Experic contractpharma
November 06, 2020
Agrees to install a TFF processing line and its associated capabilities at Experic’s cGMP facility in NJ.
JSR Life Sciences Expands European Footprint contractpharma
October 22, 2020
JSR Life Sciences, LLC is increasing its European footprint with a newly expanded, state-of-the-art facility that will co-locate primary European operations for its affiliate companies KBI Biopharma and Selexis SA.
Abzena Invests $60M Into cGMP Manufacturing Capacity contractpharma
October 10, 2020
New facility in San Diego houses a process development laboratory and two new cGMP manufacturing cleanrooms.
Thermo Fisher Launches Offering to Facilitate cGMP-Compatible Cell, Gene Therapy Manufacturing americanpharmaceuticalreview
July 29, 2020
Thermo Fisher Scientific announces the launch of a compliance and services portfolio, compatible with current Good Manufacturing Practice (cGMP) and designed to enable rapid start-up of clinical and commercial cell and gene therapy manufacturing.
ChemPartner Expands Biologics Capabilities contractpharma
June 17, 2020
Makes additional investments in biologics from research to manufacturing capabilities.

Previous page 1 2 3 4 5 6 7 8 9 Next page